Patents by Inventor Edward Paul FEENER

Edward Paul FEENER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENTS OF HEREDITARY ANGIOEDEMA
    Publication number: 20240122909
    Abstract: The present invention relates to treatments of hereditary angioedema (HAE). In particular, the present invention provides on-demand treatments of hereditary angioedema (HAE) by orally administering a plasma kallikrein inhibitor to a patient in need thereof on-demand.
    Type: Application
    Filed: February 9, 2022
    Publication date: April 18, 2024
    Inventors: Edward Paul FEENER, Sally Louise MARSH, Andreas MAETZEL, Michael David SMITH, Christopher Martyn YEA
  • TREATMENTS OF ANGIOEDEMA
    Publication number: 20230381162
    Abstract: The present invention relates to treatments of bradykinin-mediated angioedema. In particular, the present invention provides on-demand treatments of bradykinin-mediated angioedema by orally administering a plasma kallikrein inhibitor to a patient in need thereof on-demand as an oral dosage form particularly suitable for patients who may struggle to swallow tablets.
    Type: Application
    Filed: October 22, 2021
    Publication date: November 30, 2023
    Inventors: John Alexander COOPER, Edward Paul FEENER, Andreas MAETZEL, Sally Louise MARSH, Michael David SMITH, Christopher Martyn YEA
  • TREATMENTS OF DIABETIC MACULAR EDEMA AND IMPAIRED VISUAL ACUITY
    Publication number: 20220401390
    Abstract: The present invention relates to treatments of diabetic macular edema (DME) and impaired visual acuity, comprising intravitreally administering the compound of formula (A) (or a pharmaceutically acceptable salt and/or solvate thereof): Formula (A).
    Type: Application
    Filed: December 9, 2020
    Publication date: December 22, 2022
    Inventors: Edward Paul FEENER, Michael David SMITH, Christopher Martyn YEA
  • TREATMENTS OF ANGIOEDEMA
    Publication number: 20220226293
    Abstract: The present invention relates to treatments of angioedema, and specifically bradykinin-mediated angioedema non-hereditary (BK-AEnH). In particular, the present invention provides on-demand treatments of bradykinin-mediated angioedema non-hereditary (BK-AEnH) by orally administering a plasma kallikrein inhibitor to a patient in need thereof on-demand. Regular (or continuous) treatments of BK-AEnH are also provided.
    Type: Application
    Filed: June 15, 2020
    Publication date: July 21, 2022
    Inventors: Edward Paul FEENER, Sally Louise MARSH, Andreas MAETZEL, Michael David SMITH, Christopher Martyn YEA
  • TREATMENTS OF HEREDITARY ANGIOEDEMA
    Publication number: 20220218680
    Abstract: The present invention relates to treatments of hereditary angioedema (HAE). In particular, the present invention provides on-demand treatments of hereditary angioedema (HAE) by orally administering a plasma kallikrein inhibitor to a patient in need thereof on-demand. Regular (or continuous) treatments of HAE are also provided.
    Type: Application
    Filed: June 15, 2020
    Publication date: July 14, 2022
    Inventors: Edward Paul FEENER, Sally Louise MARSH, Andreas MAETZEL, Michael David SMITH, Christopher Martyn YEA